Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Overexpression of the serpin megsin induces progressive mesangial cell proliferation and expansion
Toshio Miyata, … , Satoshi Sugiyama, Kiyoshi Kurokawa
Toshio Miyata, … , Satoshi Sugiyama, Kiyoshi Kurokawa
Published March 1, 2002
Citation Information: J Clin Invest. 2002;109(5):585-593. https://doi.org/10.1172/JCI14336.
View: Text | PDF
Article Article has an altmetric score of 9

Overexpression of the serpin megsin induces progressive mesangial cell proliferation and expansion

  • Text
  • PDF
Abstract

Mesangial cells maintain normal glomerular function by mediating ECM remodeling and immune complex disposal. We have recently identified megsin, a novel member of the serine protease inhibitor (serpin) superfamily predominantly expressed in the mesangium. While our previous studies suggested a role for megsin in the pathogenesis of human glomerular diseases, its exact biological significance remained unknown. Here we produced two lines of megsin transgenic mice. Overexpression of megsin led to progressive mesangial matrix expansion and an increase in the number of mesangial cells. These glomerular lesions were accompanied by an augmented immune complex deposition, together with Ig’s and complement. Binding and functional assays in vitro identified plasmin as one biological substrate of megsin and confirmed its activity as a proteinase inhibitor. Transgenic animals exhibiting nephritis as a result of treatment with anti–glomerular basement membrane antiserum showed significantly more persistent expansion of the mesangial ECM than was seen in parental mice. Megsin therefore exerts a biologically relevant influence on mesangial function, and on the mesangial microenvironment, such that simple overexpression of this endogenous serpin engenders elementary mesangial lesions.

Authors

Toshio Miyata, Reiko Inagi, Masaomi Nangaku, Toshiyuki Imasawa, Masahiro Sato, Yuko Izuhara, Daisuke Suzuki, Atsusi Yoshino, Hiroshi Onogi, Minoru Kimura, Satoshi Sugiyama, Kiyoshi Kurokawa

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
Western blot analysis of megsin gene product. (a) Characterization of an...
Western blot analysis of megsin gene product. (a) Characterization of anti-human megsin antibody. Lane 1, human megsin fusion protein with MBP expressed in E. coli (86 kDa); lanes 2 and 4, kidneys from wild-type mice; lane 3, kidney from F1 megsin transgenic mouse (line A); lane 5, kidney from F1 megsin transgenic mouse (line B). Arrow indicates megsin product with an approximate molecular weight of 47 kDa. (b) Immunohistochemical detection of human megsin gene product in the kidneys of a wild-type mouse (left) and an F1 megsin transgenic mouse (line A) (right). ×100.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 patents
Referenced in 2 Wikipedia pages
1 readers on Mendeley
See more details